The candidate vaccine would be a “peptide-based vaccine” and began human trials on July 27, with the participation of a hundred volunteers, the newspaper wrote.
“TodayArray . . . the latest organization of 20 volunteers has been discharged from the hospital,” according to Reuters. “All 100 volunteers were vaccinated with two doses and carried out a 23-day follow-up era in the hospital. Good. “
CORONAVIRUS PATIENTS STILL HAVE LUNG LESIONS: INSPIRATION, WEEKS AFTER HOSPITAL DISCHARGE: REPORT
In addition, other researchers said that an adenovirus-based vaccine called Sputnik V “safe, well tolerated” and led to a “strong cellular and fun immune response” opposite Sars-Cov-2, based on the effects published Friday. Of Gamaleya’s National Center for Epidemiology and Microbiology Research.
Russia’s first tests were heavily criticized for receiving government approval last month after being tested on a few dozen people before being widely administered, according to the Associated Press.
Dr. Anthony Fauci, the country’s leading infectious disease specialist, issued warnings.
“We have to be careful when we hear from Russia or China or any other position that they have a vaccine they know works,” Fauci told Healthline last month. “They would probably have a product they’re willing to take on the threat from. give it to other people without necessarily seeming still that it is effective or safe . . . “
Interfax would have said that the effects would occur on 30 September, depending on the point of sale.
Amy McGorry of Fox News contributed to this report.
CLICK HERE FOR THE FOX NEWS APP